The U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive, ORTHO TRI-CYCLEN® LO (norgestimate/ethinyl estradiol) Tablets for the prevention of pregnancy.
ORTHO TRI-CYCLEN LO will be available by prescription in the fall. Like other oral contraceptives, ORTHO TRI-CYCLEN LO, is highly effective when taken correctly.
It contains a combination of hormones — 25 micrograms (mcg) of estrogen and the progestin, norgestimate — which provides excellent cycle control and tolerability.
ORTHO TRI-CYCLEN LO was developed by Ortho-McNeil Pharmaceutical, Inc., the leader in the U.S. contraceptive market and the maker of ORTHO TRI-CYCLEN® (norgestimate/ethinyl estradiol) Tablets, the nation’s #1 prescribed birth control pill and the first to be FDA-approved to improve moderate acne and help maintain clearer skin.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!